Finasteride
- Level
- Commodity
- Parent
- 51182000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51182001This classification denotes a 5 alpha-reductase inhibitor and anti-androgen with the molecular formula C23H36N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 57GNO57U7G, chemically known as 4-azaandrost-1-ene-17-carboxamide, n-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)- but generally known as finasteride, which bears US NIH Compound Identifier 57363. European Medicines Agency schedules Finasteride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07629MIG. The term FINASTERIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 4, No. 3 1990, List 30). World Health Organization schedules finasteride in its Anatomical Therapeutic Chemical (ATC) Classification. FINASTERIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule finasteride under HS 29372900 and SITC 54153. As of Q4 2014, FINASTERIDE remains the US FDA Preferred Term for this commodity. Finasteride bears US NLM identifiers UMLS ID C0060389 and NCI Concept Code C1099. SMILES: O=C(NC(C)(C)C)C1C2(C(C3C(C4(C(NC(=O)C=C4)CC3)C)CC2)CC1)C.
Same parent
Under 51182000 · 73Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.